Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now

"The greatest wealth is health."         - Virgil


      Advertisement

IMPLANT SITE INFECTION side effect

What is IMPLANT SITE INFECTION ?
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with IMPLANT SITE INFECTION

ARIXTRA  AVONEX  CETUXIMAB  DURAGESIC  FLEX  FLUOROURACIL  


IMPLANT SITE INFECTION : Avonex Side Effects Report #5637924-3
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Feb 07, 2008. Female patient, 54 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: implant site infection, purulence, wound infection, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.

IMPLANT SITE INFECTION : Flex Side Effects Report #5586789-7
FLEX HD problem was reported by a Physician from UNITED STATES on Nov 06, 2007. Female patient was diagnosed with soft tissue disorder and was treated with FLEX HD. After drug was administered, patient experienced the following problems/side effects: implant site infection, post procedural infection, . FLEX HD dosage: unknown. Patient was hospitalized. Patient recovered.

IMPLANT SITE INFECTION : Fluorouracil Side Effects Report #5441903-9
Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on Aug 30, 2007. Male patient, weighting 219.4 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: implant site infection, open wound, purulent discharge, urinary tract infection, . FLUOROURACIL dosage: 5600 MG. Patient recovered.

IMPLANT SITE INFECTION : Cetuximab Side Effects Report #5416832-7
CETUXIMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2007. Male patient, weighting 172.0 lb, was diagnosed with pancreatic carcinoma and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: blood culture positive, implant site infection, serratia infection, . CETUXIMAB dosage: 492MG IV. During the same period patient was treated with GEMICTABINE, OXALIPLATIN, CLONAZEPAM, AVODART, NEXIUM, ZYRTEC, PAXIL. Patient was hospitalized. Patient recovered.

IMPLANT SITE INFECTION : Arixtra Side Effects Report #5386129-2
Pharmacist from UNITED STATES reported ARIXTRA problem on July 11, 2007. Male patient was diagnosed with deep vein thrombosis, disease recurrence and was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: implant site haematoma, implant site infection, . ARIXTRA dosage: 7.5MG QD SQ. During the same period patient was treated with WARFARIN. Patient was hospitalized. Patient recovered.

IMPLANT SITE INFECTION : Arixtra Side Effects Report #5386129-2
ARIXTRA problem was reported by a Pharmacist from UNITED STATES on July 11, 2007. Male patient was diagnosed with deep vein thrombosis, disease recurrence and was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: implant site haematoma, implant site infection, . ARIXTRA dosage: 7.5MG QD SQ. During the same period patient was treated with WARFARIN. Patient was hospitalized. Patient recovered.

IMPLANT SITE INFECTION : Duragesic Side Effects Report #5383871-4
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on July 02, 2007. Male patient, weighting 200.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: hospitalisation, hyperhidrosis, implant site infection, . DURAGESIC dosage: unknown. During the same period patient was treated with DILAUDID. Patient was hospitalized. Patient recovered.

IMPLANT SITE INFECTION : Duragesic Side Effects Report #5383871-4
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on July 02, 2007. Male patient, weighting 200.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: hospitalisation, hyperhidrosis, implant site infection, . DURAGESIC dosage: unknown. During the same period patient was treated with DILAUDID. Patient was hospitalized. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about IMPLANT SITE INFECTION side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about IMPLANT SITE INFECTION